Information about LV Pharma
My details
*
*
*

Company information

Status
Active

Enterprise number

BE0758.798.435

VAT liability
Yes
Established
26-11-2020
Last balance sheet year
2025
Company size
Small 0 FTE
Legal form
Société à responsabilité limitée (SRL)
Principal activity
Activities of holding companies
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

7-day free trial, no credit card required.

Financial data from LV Pharma

2025 2024 2023 2022
Income statement
Profit/Loss € 93,711 57% € 59,807 > 1000% € 2,098 -94% € 35,670
Gross margin € 182,309 45% € 125,909 467% € 22,202 -53% € 46,870
Balance sheet
Balance sheet total € 1,442,617 4% € 1,392,611 2% € 1,369,392 > 1000% € 99,490
Equity € 227,464 70% € 133,753 81% € 73,946 3% € 71,849
Debts € 1,215,153 -3% € 1,258,858 -3% € 1,295,446 > 1000% € 27,641

Publications from LV Pharma

Date Publication
30-11-2020 Rubric Constitution (New Juridical Person, Opening Branch, etc...) (NL)

Frequently asked questions

What is the VAT number of LV Pharma?
The VAT number of LV Pharma is BE 0758.798.435.
Wat is the PEPPOL ID of LV Pharma?
The PEPPOL ID of LV Pharma is 0208:0758798435. Log in or start a free trial to see the full overview.
When was LV Pharma founded?
LV Pharma was founded on 26-11-2020.
What is the address of LV Pharma?
The current registered office of LV Pharma is located at De Loecht(wie) 1, 2222 Heist-op-Den-Berg.
When was the last time LV Pharma filed their annual financial statements?
The most recent financial statements of LV Pharma were filed on 11-08-2026.
How many employees does LV Pharma have?
There are currently no employees working at LV Pharma or no workforce information is available.
What is the annual turnover of LV Pharma?
At the time of its most recent financial statements, LV Pharma did not publish any turnover figures. LV Pharma reported a gross margin of €182,309.33.